Pharmaceuticals in Japan - 麻豆原创 Summary, Competitive Analysis and Forecast, 2016-2025
Summary
Pharmaceuticals in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Japanese pharmaceuticals market had total revenues of $87.0bn in 2020, representing a compound annual growth rate (CAGR) of 9.3% between 2016 and 2020.
- Japan鈥檚 aging population is likely to balance the downwards pressure on drug prices, helping to maintain positive growth in the market over the forecast period.
- As Japan plans to embark on its vaccination program in 2021 to control the spread of COVID-19, the procurement of safe and effective vaccines could produce significant revenues for pharmaceutical companies.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Japan
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Japan
- Leading company profiles reveal details of key pharmaceuticals market players鈥� global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Japan pharmaceuticals market with five year forecasts
Reasons to Buy
- What was the size of the Japan pharmaceuticals market by value in 2020?
- What will be the size of the Japan pharmaceuticals market in 2025?
- What factors are affecting the strength of competition in the Japan pharmaceuticals market?
- How has the market performed over the last five years?
- What are the main segments that make up Japan's pharmaceuticals market?
Table of Contents
1 Executive Summary
1.1. 麻豆原创 value
1.2. 麻豆原创 value forecast
1.3. Geography segmentation
1.4. 麻豆原创 share
1.5. 麻豆原创 rivalry
1.6. Competitive Landscape
2 麻豆原创 Overview
2.1. 麻豆原创 definition
2.2. 麻豆原创 analysis
3 麻豆原创 Data
3.1. 麻豆原创 value
4 麻豆原创 Segmentation
4.1. Geography segmentation
5 麻豆原创 Outlook
5.1. 麻豆原创 value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. 麻豆原创 share
7.2. Who are the leading players?
7.3. What strategies do leading players follow?
7.4. What are the weaknesses of leading players?
7.5. Is there any significant M&A activity on the horizon for next year?
8 Company Profiles
8.1. Daiichi Sankyo Co Ltd
8.2. Astellas Pharma Inc.
8.3. Mitsubishi Tanabe Pharma Corporation
8.4. Takeda Pharmaceutical Company Limited
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related 麻豆原创Line research
10.4. About 麻豆原创Line
List of Tables
List of Tables
Table 1: Japan pharmaceuticals market value: $ billion, 2016-20
Table 2: Japan pharmaceuticals market geography segmentation: $ billion, 2020
Table 3: Japan pharmaceuticals market value forecast: $ billion, 2020-25
Table 4: Japan pharmaceuticals market share: % share, by value, 2020
Table 5: Daiichi Sankyo Co Ltd: key facts
Table 6: Daiichi Sankyo Co Ltd: Annual Financial Ratios
Table 7: Daiichi Sankyo Co Ltd: Key Employees
Table 8: Daiichi Sankyo Co Ltd: Key Employees Continued
Table 9: Astellas Pharma Inc.: key facts
Table 10: Astellas Pharma Inc.: Annual Financial Ratios
Table 11: Astellas Pharma Inc.: Key Employees
Table 12: Astellas Pharma Inc.: Key Employees Continued
Table 13: Mitsubishi Tanabe Pharma Corporation: key facts
Table 14: Mitsubishi Tanabe Pharma Corporation: Key Employees
Table 15: Takeda Pharmaceutical Company Limited: key facts
Table 16: Takeda Pharmaceutical Company Limited: Annual Financial Ratios
Table 17: Takeda Pharmaceutical Company Limited: Annual Financial Ratios (Continued)
Table 18: Takeda Pharmaceutical Company Limited: Key Employees
Table 19: Takeda Pharmaceutical Company Limited: Key Employees Continued
Table 20: Japan size of population (million), 2016-20
Table 21: Japan gdp (constant 2005 prices, $ billion), 2016-20
Table 22: Japan gdp (current prices, $ billion), 2016-20
Table 23: Japan inflation, 2016-20
Table 24: Japan consumer price index (absolute), 2016-20
Table 25: Japan exchange rate, 2016-20
List of Figures
List of Figures
Figure 1: Japan pharmaceuticals market value: $ billion, 2016-20
Figure 2: Japan pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 3: Japan pharmaceuticals market value forecast: $ billion, 2020-25
Figure 4: Forces driving competition in the pharmaceuticals market in Japan, 2020
Figure 5: Drivers of buyer power in the pharmaceuticals market in Japan, 2020
Figure 6: Drivers of supplier power in the pharmaceuticals market in Japan, 2020
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Japan, 2020
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Japan, 2020
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Japan, 2020
Figure 10: Japan pharmaceuticals market share: % share, by value, 2020
Daiichi Sankyo Co Ltd
Astellas Pharma Inc.
Mitsubishi Tanabe Pharma Corporation
Takeda Pharmaceutical Company Limited
听
听
*If Applicable.
